Home > Qtrly Results > BLISS GVS PHARMA

BLISS GVS PHARMA
Quarterly Results Analysis [Mar2025]

BLISS GVS PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Quarterly Results

Consolidated Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
Audited
Jun2024
Audited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
Audited
Jun2023
UnAudited
Revenues ₹198 Cr ₹210 Cr ₹218 Cr ₹184 Cr ₹198 Cr ₹201 Cr ₹212 Cr ₹160 Cr
Expenses ₹177 Cr ₹181 Cr ₹176 Cr ₹149 Cr ₹170 Cr ₹157 Cr ₹158 Cr ₹135 Cr
Operating Income ₹21 Cr ₹30 Cr ₹41 Cr ₹34 Cr ₹28 Cr ₹44 Cr ₹54 Cr ₹24 Cr
Other Income ₹12 Cr ₹15 Cr ₹5 Cr ₹4 Cr ₹6 Cr ₹5 Cr ₹13 Cr ₹5 Cr
Interest ₹2 Cr ₹1 Cr ₹4 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹1 Cr ₹1 Cr
Depreciation ₹8 Cr ₹8 Cr ₹7 Cr ₹7 Cr ₹7 Cr ₹7 Cr ₹6 Cr ₹6 Cr
Profit Before Tax ₹23 Cr ₹36 Cr ₹36 Cr ₹30 Cr ₹-4 Cr ₹40 Cr ₹59 Cr ₹22 Cr
Profit After Tax ₹17 Cr ₹26 Cr ₹26 Cr ₹22 Cr ₹-5 Cr ₹29 Cr ₹43 Cr ₹14 Cr
EPS ₹1.47 ₹2.26 ₹2.31 ₹1.97 ₹-0.87 ₹2.64 ₹4.05 ₹1.41
Industry Peers & Returns1W1M1Y
BLISS GVS PHARMA -6.1% 9.6% 30.3%
SUN PHARMACEUTICAL INDUSTRIES -1.3% -3.3% 8.3%
DIVIS LABORATORIES -1.5% 0.8% 42.3%
CIPLA -1.7% 2.3% -5.8%
TORRENT PHARMACEUTICALS -3.3% -1.4% 9.8%
DR REDDYS LABORATORIES -1.6% 8.4% 10.6%
MANKIND PHARMA -3.3% -6.1% 3.4%
ZYDUS LIFESCIENCES -1.8% 5.9% -12%
LUPIN -3.2% -1.1% 22.1%

BLISS GVS PHARMA Quarterly Revenues

Revenues
Q-o-Q

-5.91 %

Y-o-Y

-0.07 %

Quarters Revenues % Change
Mar2025 ₹198 Cr
-5.91
Dec2024 ₹210 Cr
-3.34
Sep2024 ₹218 Cr
18.53
Jun2024 ₹184 Cr
-7.31
Mar2024 ₹198 Cr
-1.29
Dec2023 ₹201 Cr
-5.27
Sep2023 ₹212 Cr
32.82
Jun2023 ₹160 Cr -

BLISS GVS PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-29.22 %

Y-o-Y

-25.61 %

Quarters Operating Profit % Change
Mar2025 ₹21 Cr
-29.22
Dec2024 ₹30 Cr
-28.18
Sep2024 ₹41 Cr
20.82
Jun2024 ₹34 Cr
21.11
Mar2024 ₹28 Cr
-35.12
Dec2023 ₹44 Cr
-19.63
Sep2023 ₹54 Cr
124.54
Jun2023 ₹24 Cr -
Operating Margins
Q-o-Q

-24.79 %

Y-o-Y

-25.58 %

Quarters Operating Margin% % Change
Mar2025 10.65%
-24.79
Dec2024 14.16%
-25.71
Sep2024 19.06%
1.98
Jun2024 18.69%
30.61
Mar2024 14.31%
-34.27
Dec2023 21.77%
-15.16
Sep2023 25.66%
69.04
Jun2023 15.18% -

BLISS GVS PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-35.46 %

Y-o-Y

Positive

Quarters Profit After Tax % Change
Mar2025 ₹17 Cr
-35.46
Dec2024 ₹26 Cr
0.42
Sep2024 ₹26 Cr
16.23
Jun2024 ₹22 Cr
Positive
Mar2024 ₹-5 Cr
Negative
Dec2023 ₹29 Cr
-32.46
Sep2023 ₹43 Cr
199.46
Jun2023 ₹14 Cr -
PAT Margins
Q-o-Q

-31.40 %

Y-o-Y

Positive

Quarters PAT Margin(%) % Change
Mar2025 8.41 %
-31.40
Dec2024 12.26 %
3.90
Sep2024 11.8 %
-1.99
Jun2024 12.04 %
Positive
Mar2024 -2.48 %
Negative
Dec2023 14.48 %
-28.74
Sep2023 20.32 %
125.53
Jun2023 9.01 % -

BLISS GVS PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-34.96 %

Y-o-Y

Positive

Quarters EPS % Change
Mar2025 ₹1.47
-34.96
Dec2024 ₹2.26
-2.16
Sep2024 ₹2.31
17.26
Jun2024 ₹1.97
Positive
Mar2024 ₹-0.87
Negative
Dec2023 ₹2.64
-34.81
Sep2023 ₹4.05
187.23
Jun2023 ₹1.41 -

You may also like the below Video Courses